Edition:
United Kingdom

Genmab A/S (GEN.CO)

GEN.CO on Copenhagen Stock Exchange

998.00DKK
2:49pm GMT
Change (% chg)

kr.-13.00 (-1.29%)
Prev Close
kr.1,011.00
Open
kr.1,012.50
Day's High
kr.1,021.50
Day's Low
kr.986.80
Volume
130,154
Avg. Vol
219,210
52-wk High
kr.1,335.00
52-wk Low
kr.786.20

Chart for

About

Genmab A/S is a Denmark-based biotechnology company. It is engaged in the development of differentiated human antibody therapeutics for the treatment of cancer, as well as other medical conditions, such as relapsing remitting multiple sclerosis. Its product pipeline includes a number of research and development projects in... (more)

Overall

Beta: 1.27
Market Cap(Mil.): kr.85,016.77
Shares Outstanding(Mil.): 61.16
Dividend: --
Yield (%): --

Financials

  GEN.CO Industry Sector
P/E (TTM): 63.56 69.44 33.70
EPS (TTM): 21.87 -- --
ROI: 29.46 8.92 14.45
ROE: 29.47 10.08 15.96

Earnings vs. Estimates